Jeannie Visootsak1, Heather Hipp2, Heather Clark2, Elizabeth Berry-Kravis3, Tovi Anderson2, Dawn Laney2. 1. Department of Human Genetics, Emory University, Atlanta, GA. Electronic address: Jvisoot@emory.edu. 2. Department of Human Genetics, Emory University, Atlanta, GA. 3. Departments of Pediatrics, Neurological Sciences, and Biochemistry, Rush University Medical Center, Chicago, IL.
Abstract
OBJECTIVE: To determine the average number of family members diagnosed with a Fragile X Mental Retardation-1 (FMR1) mutation after a proband receives the initial diagnosis of fragile X syndrome (FXS). STUDY DESIGN: We reviewed pedigrees of families who had been evaluated at the Fragile X Syndrome Center at Emory University in Atlanta, Georgia. Through these pedigrees, we determined the number of additional family members diagnosed as FMR1 premutation carriers or with full mutation FXS after the initial diagnosis in each proband. RESULTS: The fragile X pedigree review identified 176 probands, including 108 males (61%) and 68 females (39%). A total of 785 family members were diagnosed with expanded fragile X alleles, including 278 males (35%) and 507 females (65%). These family members included 227 individuals with full mutation FXS (219 males and 8 females) and 558 premutation carriers (59 males and 499 females). After the initial diagnosis of a proband with FXS, on average at least 5 additional family members were diagnosed with an FMR1 mutation. CONCLUSION: Our findings confirm that obtaining a detailed family history after diagnosis of a proband with FXS is likely to identify multiple family members with FMR1 mutations. It is important that the pediatrician or other health care provider making a diagnosis of FXS recognize the value of a detailed family history for timely diagnosis and treatment of additional individuals who may be FMR1 premutation carriers or have full mutation FXS.
OBJECTIVE: To determine the average number of family members diagnosed with a Fragile X Mental Retardation-1 (FMR1) mutation after a proband receives the initial diagnosis of fragile X syndrome (FXS). STUDY DESIGN: We reviewed pedigrees of families who had been evaluated at the Fragile X Syndrome Center at Emory University in Atlanta, Georgia. Through these pedigrees, we determined the number of additional family members diagnosed as FMR1 premutation carriers or with full mutation FXS after the initial diagnosis in each proband. RESULTS: The fragile X pedigree review identified 176 probands, including 108 males (61%) and 68 females (39%). A total of 785 family members were diagnosed with expanded fragile X alleles, including 278 males (35%) and 507 females (65%). These family members included 227 individuals with full mutation FXS (219 males and 8 females) and 558 premutation carriers (59 males and 499 females). After the initial diagnosis of a proband with FXS, on average at least 5 additional family members were diagnosed with an FMR1 mutation. CONCLUSION: Our findings confirm that obtaining a detailed family history after diagnosis of a proband with FXS is likely to identify multiple family members with FMR1 mutations. It is important that the pediatrician or other health care provider making a diagnosis of FXS recognize the value of a detailed family history for timely diagnosis and treatment of additional individuals who may be FMR1 premutation carriers or have full mutation FXS.
Authors: Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone Journal: Am J Med Genet A Date: 2012-12-13 Impact factor: 2.802
Authors: Agustini Utari; Weerasak Chonchaiya; Susan M Rivera; Andrea Schneider; Randi J Hagerman; Sultana M H Faradz; Iryna M Ethell; Danh V Nguyen Journal: Am J Intellect Dev Disabil Date: 2010-09
Authors: Alyssa A Hamlin; Dina Sukharev; Luis Campos; Yi Mu; Flora Tassone; David Hessl; Danh V Nguyen; Danuta Loesch; Randi J Hagerman Journal: Am J Med Genet A Date: 2012-04-23 Impact factor: 2.802
Authors: David Hessl; John M Wang; Andrea Schneider; Kami Koldewyn; Lien Le; Christine Iwahashi; Katherine Cheung; Flora Tassone; Paul J Hagerman; Susan M Rivera Journal: Biol Psychiatry Date: 2011-07-23 Impact factor: 13.382
Authors: Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman Journal: Am J Med Genet A Date: 2008-04-15 Impact factor: 2.802
Authors: Meredith M Renda; Robert G Voigt; Dusica Babovic-Vuksanovic; W Edward Highsmith; Sherry S Vinson; Christine M Sadowski; Randi J Hagerman Journal: J Child Neurol Date: 2012-12-23 Impact factor: 1.987
Authors: Naomi J Goodrich-Hunsaker; Ling M Wong; Yingratana McLennan; Flora Tassone; Danielle Harvey; Susan M Rivera; Tony J Simon Journal: Front Hum Neurosci Date: 2011-07-14 Impact factor: 3.169